dopexamine has been researched along with Acute Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beale, R; Bihari, D; Jackson, L; Smithies, M; Yee, TH | 1 |
Asanoi, H; Ishimura, T; Kinoshita, M; Lee, JD; Mitsudo, K; Morioka, S; Sakurai, T; Sasayama, S; Sato, H; Yoshikawa, J | 1 |
1 trial(s) available for dopexamine and Acute Disease
Article | Year |
---|---|
Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study.
Topics: Acute Disease; Adult; Aged; Dopamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Single-Blind Method; Substance Withdrawal Syndrome; Vasodilator Agents | 1995 |
1 other study(ies) available for dopexamine and Acute Disease
Article | Year |
---|---|
Protecting the gut and the liver in the critically ill: effects of dopexamine.
Topics: Acute Disease; Adult; Aged; Blood Gas Analysis; Critical Illness; Dopamine; Female; Gastric Acidity Determination; Hemodynamics; Hospital Mortality; Humans; Hydrogen-Ion Concentration; Indocyanine Green; Infusions, Intravenous; Liver Circulation; Male; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure; Oxygen Consumption; Prospective Studies; Respiratory Insufficiency; Severity of Illness Index; Shock, Septic; Splanchnic Circulation; Syndrome; Vasodilator Agents | 1994 |